Early intervention with Ustekinumab is associated with higher rates of clinical and endoscopic remission in patients with Crohn’s disease

Background: Early biologic intervention after diagnosis has shown improved clinical and endoscopic outcomes in patients with Crohn’s disease (CD), while very little is known about the effectiveness of early versus late administration of Ustekinumab (UST). Objectives: We aimed to compare early versus...

Celý popis

Podrobná bibliografie

Hlavní autoři:	Tong Tu, Mengqi Chen, Manying Li, Linxin Liu, Zihan Chen, Jianming Lin, Baili Chen, Yao He, Minhu Chen, Zhirong Zeng, Xiaojun Zhuang
Médium:	Artigo
Jazyk:	Inglês
Vydáno:	SAGE Publishing 2024-12-01
Edice:	Therapeutic Advances in Gastroenterology
On-line přístup:	https://doi.org/10.1177/17562848241307596
Tagy:	Přidat tag Žádné tagy, Buďte první, kdo vytvoří štítek k tomuto záznamu!